S&P 500
5,912.59
+0.0%
+$0.90
DJI
42,102.48
-0.4%
-$167.59
NASDAQ
19,183.65
+0.4%
+$69.89
Bitcoin
104,238.00
-0.9%
-955.14
AAPL
$201.03
+0.1%
+$0.18
AMZN
$205.91
+0.4%
+$0.90
GOOG
$170.40
-1.4%
-$2.45
META
$666.00
+2.9%
+$18.51
MSFT
$461.37
+0.2%
+$1.01
NVDA
$137.68
+1.9%
+$2.55
TSLA
$338.11
-2.4%
-$8.35
Moleculin Biotech (NASDAQ: MBRX)
$0.92
(5.2%)
$0.05
Price as of June 2, 2025, 12:54 p.m. ET
Moleculin Biotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Moleculin Biotech Company Info
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.